Respiratory Exchange

Dr. Fred Hsieh discusses eosinophilic-related diseases and their possible causes, such as allergic diseases or parasitic infection. He covers the best way to proceed when your CBC report shows a high eosinophil number and what hypereosinophilia syndrome actually is. Dr. Hsieh reviews the challenge in treating eosinophilic-related diseases with corticosteroids, and new, FDA-approved treatments that use eosinophil-targeting biologics to reduce the eosinophils in the blood.

ATS LIVE! Part 2 Interviews from the 2023 American Thoracic Society Conference Host: Amy Attaway, MD Recorded live at ATS, Dr. Amy Attaway talks with attendees about their emerging and innovative work. Dr. Anna May: Medication use before starting positive airway pressure therapy. Dr. Neha Solanki: Platelets’ association with severe asthma. Dr. Peng Zhang: Repurposing medications to decrease asthma inflammation. Dr. Uddalak Majumdar: Mechanical ventilation and obstructive airway diseases.

Recorded live at ATS, Dr. Amy Attaway, Associate Director of the Cleveland Clinic COPD Center, talks with attendees about their emerging and innovative work:•Dr. Elizabeth Regan: COPDGene study.•Drs. Onder Yildirim and Thom Conlon: COPD iNET.•Dr. Roger Kim: AI radio mix tool. Racial disparities in lung cancer screening.

Dr. Rachel Scheraga and Dr. Brian Southern in the Respiratory Institute at the Cleveland Clinic, cover the best of the 2023 ATS conference. They highlight discussions on recent IPF trials, omics and spatial transcriptomics, incorporating wearables data in clinical trials, climate change impact on lung disease risk and behavior, the updated pulmonary hypertension guidelines and more.

This underrecognized disease is too often diagnosed late in the fungal infection’s fibrotic progression. Learn how using a combination of CT scans, bronchoscopy and the assistance of interventional radiologists can help you diagnose and differentiate fibrosing mediastinitis from other pulmonary disorders such as asthma or COPD. Also in this episode, multiple palliative modalities for fibrosing mediastinitis are discussed that can help improve the quality of life of your patient.

Occupational lung disease is anything related to exposures that occurred on the job. This includes something that may be happening now or happened 20, 30 years ago. Hear why talking to your patient about their job or deployment history may be key to determining lung disease origin and developing a successful treatment plan.

Dr. Maryam Valapour, director of Lung Transplant Outcomes Research at Cleveland Clinic, discusses the intersection of transplant science and health policy and the role of the physician-scientist. She also covers the need to build better lung allocation models, the concept of minimizing the impact of geography in organ distribution, looking into who doesn't get access to transplant that should and increasing the organ donor pool.

Alpha-1 antitrypsin deficiency is a genetic disease that commonly goes unrecognized. For some patients who have COPD or emphysema, alpha-1 is a predisposing condition they have that can be identified through a simple blood test. In this episode, Dr. James Stoller discusses this disease, effective therapies and novel treatments being investigated that include corrector molecules, gene editing approaches and more.

Military burn pits were used during deployment to burn away any kind of waste created. The fumes produced have caused serious lung injury and disease. Drs. Mauve MacMurdo and Neha Solanki discuss burn pit exposure, legislation designed to help military who have developed deployment-related lung disease, and the need to evaluate and support these patients.

Dr. Peter Mazzone talks with Drs. Sethi Sonali and Angel Coz about some of the highlights from the CHEST 2022 conference, including the two-part Critical Care Year End Review covering mechanical ventilation, neurology, ICU, sepsis, ARDIS and surgical critical care.